tradmap

WAT Waters Corporation

$413.64 +0.36%

Updated

S&P 500 Companies

Held by SPYVOOIVV

Healthcare · Laboratory Analytical Instruments

Waters Corporation (WAT) is a healthcare company in the Laboratory Analytical Instruments industry, with a market capitalization of $40.6 billion. Shares last traded at $413.64, near their 52-week high. Over the past year the stock is up 42.5%. WAT trades at a price-to-earnings ratio of 63.24, above the Laboratory Analytical Instruments median of 43.69. Net profit margin is 13.8%, above the peer median of -1.7%. Revenue grew 7.0% year over year.

Market Cap
$40.6B
Shares Out
98.2M
EPS (TTM)
$8.32
P/E Ratio
49.72
P/S Ratio
8.75
P/B Ratio
2.67
Dividend / Share
Dividend Yield
52-Week High
$426.13
52-Week Low
$282.97
Volume
26,935
Avg Vol (3m)
61,357.921

Performance

1W
-1.80%
1M
+3.40%
3M
+9.88%
6M
+31.13%
YTD
+8.35%
1Y
+42.51%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
57.13
SMA (50)
$391.03
SMA (200)
$360.64
Price vs SMA50
+5.78%
Price vs SMA200
+14.70%
ATR (14)
$11.67

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$4.6B
Net Income
$643M
Gross Margin
25.8%
Operating Margin
7.1%
Net Margin
13.8%
Return on Equity
4.2%
Return on Assets
2.6%
Current Ratio
1.86
Debt / Equity
0.32
Revenue Growth (YoY)
+7.0%

Latest reported annual period ending 2026-07-04 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 $-2.31 2026-08-11
Q1 2026 $-0.87 2026-05-12
FY 2025 $10.76 2026-02-23
FY 2025 $2.50 2026-02-23
Q3 2025 $7.00 2025-11-04
FY 2025 $2.47 2026-02-23

Full earnings history →

Laboratory Analytical Instruments peers

WAT vs 14 industry peers (Laboratory Analytical Instruments), by market cap. Updated

P/E vs peers
63.24 / 43.69 med
+45% premium
P/S vs peers
8.75 / 5.01 med
+75% premium
Net margin vs peers
13.8% / -1.7% med
above median
1–14 of 14
AAgilent Technologies$42.3B29.355.7319.5%-0.93%
WATWaters Corporation$40.6B63.248.7513.8%+0.36%
ILMNIllumina, Inc.$33.5B40.587.4518.4%+3.90%
MTDMettler Toledo$27.2B30.016.5821.9%-0.77%
RVTYRevvity$14.6B61.375.018.2%-0.24%
BIOBio-Rad Laboratories, Inc.$10.4B46.814.028.6%-0.19%
AVTRAvantor, Inc.$10.4B-18.811.58-8.4%+3.65%
BRKRBruker Corp$9.1B-127.122.59-2.0%+0.61%
TXG10x Genomics, Inc.$8.2B-108.5013.21-12.2%+2.45%
ALMRAlamar Biosciences, Inc.$2.1B+0.51%
CTKBCytek Biosciences, Inc.$611M-9.182.96-32.2%+0.21%
MASS908 Devices Inc.$414M-11.956.81-57.0%-3.05%
PACBPacific Biosciences Of California, Inc.$403M-3.06-1.52%
EYPTEyepoint, Inc.$394M-1.28-4.39%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.